// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
The scale and speed of the global vaccine research and development effort in response to COVID-19
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr